Diagnolita
+370 688 12972
info@diagnolita.lt
  • LT
0
  • Shop
    • COVID-19 PCR test
    • Non-invasive prostate cancer test
  • FAQ
  • Contacts
  • About COVID-19 PCR saliva testing
  • About prostate cancer
  • About SARS-CoV-2 virus
  • Cart
  • Checkout
  • Contacts
  • COVID-19 diagnostics
  • FAQ
  • Homepage
  • My account
  • Privacy policy
  • Prostate cancer biomarker test
  • Prostate cancer diagnosis
  • Prostate Cancer Risk Calculator
  • Research scheme
  • Samples of Diagnolita‘s test results
  • Shop
  • Test Result
  • Test Result: Invalid
  • Test Result: Negative
  • Test Result: Pending
  • Test Result: Positive

Category: Prostate cancer biomarker test

Is Diagnolita’s prostate cancer test reliable?

How long does it take to receive the test results?

What is the price of the test?

Symptoms of prostate cancer.

How is the test done?

Why should one take the test?

What is the intended use of Diagnolita’s test?

  • «
  • 1
  • 2

JSC „Diagnolita“

Company code: 303128944
VAT code: LT100008093814

Diagnostics center

Vilnius University Technology Business Incubator, Saulėtekio alėja.
Saulėtekio alėja 7C, Vilnius, LT-10257

info@diagnolita.lt

+370 688 12972

Working hours

I-IV: 8 – 17 val.


V: 8 – 16 val.

COVID-19 virus

  • COVID-19 PCR test
  • About SARS-CoV-2 virus
  • COVID-19 diagnostics
  • About COVID-19 PCR saliva testing
  • Research scheme

Prostate cancer

  • Prostate cancer biomarker test
  • About prostate cancer
  • Prostate cancer biomarker test
  • Prostate cancer diagnosis
  • Samples of Diagnolita‘s test results
  • Prostate Cancer Risk Calculator

For clients

  • My account
  • Frequently asked questions

2023 © UAB „Diagnolita“.
All rights reserved. Privacy policy

https://www.linkedin.com/company/diagnolita/about/ https://www.facebook.com/diagnolita.lt

Solution: Verslum.lt

Cookies are used for statistical and marketing purposes. By pressing “I agree” button or continuing to browse, you confirm that. More about cookies and their withdrawn, please read our Privacy policy.